AN OVERVIEW ON ANALYTICAL METHODS FOR DAPAGLIFLOZIN – AN ANTIDIABETIC DRUGAbstract
Dapagliflozin (DAPA) is a drug of gliflozin class. It is a white crystalline solid. Dapagliflozin is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Dapagliflozin blocks glucose reabsorption into the kidney, resulting in the elimination of blood glucose through the urine. DAPA is not official in any pharmacopeia. It comes under EU Pharmaceutical Product Classes, as per literature survey. Till date officially no analytical method has been developed or reported for this drug. This review focuses on collective literature on the analytical methods developed for DAPA.
B. V. Suma * and R. Deveswaran
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M. S. Ramaiah University of Applied Sciences, Bangalore, Karnataka, India.
05 September 2018
28 December 2018
30 December 2018
01 June 2019